Trials / Completed

CompletedNCT00001995

A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS

Status: Completed
Phase: N/A
Study type: Interventional
Enrollment: 200 (planned)

Sponsor: Pharmacia · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

To determine if a drug regimen containing rifabutin will eradicate or decrease the numbers of Mycobacterium avium complex (MAC) organisms in blood, improve the symptoms associated with MAC infection, and increase survival in patients with AIDS. To assess the safety of the drug regimen.

Conditions

Mycobacterium Avium-Intracellulare Infection
HIV Infections

Interventions

Type	Name	Description
DRUG	Rifabutin

Timeline

First posted: 2001-08-31
Last updated: 2005-06-24

Locations

22 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00001995. Inclusion in this directory is not an endorsement.